Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page
- Check2 days agoChange DetectedAdded related topics links for Prostate cancer and MedlinePlus Genetics, affecting navigation but not study data or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now includes a Results section with primary and secondary outcomes and updated study dates (start, primary completion, study completion) and enrollment. This provides current information about the trial findings and status.SummaryDifference0.4%

- Check30 days agoChange DetectedDeleted a MedlinePlus Genetics topic related to Prostate cancer, removing it from the page's core topics.SummaryDifference0.2%

- Check37 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference2%

- Check44 days agoChange DetectedAdded MedlinePlus Genetics topic: Prostate cancer and updated the revision from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check52 days agoChange Detected- Removed a MedlinePlus Genetics topic on Prostate cancer, reducing genetic-disease content and potentially narrowing the scope of informational topics available on the page.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.